• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Barclays initiated coverage on Avidity Biosciences with a new price target

    8/28/24 7:52:56 AM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $RNA alert in real time by email
    Barclays initiated coverage of Avidity Biosciences with a rating of Overweight and set a new price target of $63.00
    Get the next $RNA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RNA

    DatePrice TargetRatingAnalyst
    6/17/2025$55.00Outperform
    Wolfe Research
    6/11/2025$65.00Strong Buy
    Raymond James
    3/13/2025$70.00Buy
    Citigroup
    3/12/2025$72.00Outperform
    BMO Capital Markets
    3/7/2025$70.00Sector Outperform
    Scotiabank
    12/20/2024$72.00Buy
    H.C. Wainwright
    11/26/2024$67.00Outperform
    RBC Capital Mkts
    9/24/2024$59.00Buy
    Goldman
    More analyst ratings

    $RNA
    SEC Filings

    See more
    • Avidity Biosciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Avidity Biosciences, Inc. (0001599901) (Filer)

      6/10/25 4:51:54 PM ET
      $RNA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Avidity Biosciences Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - Avidity Biosciences, Inc. (0001599901) (Filer)

      6/9/25 7:05:55 AM ET
      $RNA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Avidity Biosciences Inc.

      SCHEDULE 13G/A - Avidity Biosciences, Inc. (0001599901) (Subject)

      5/14/25 12:15:55 PM ET
      $RNA
      Biotechnology: Pharmaceutical Preparations
      Health Care